News

MGI Tech's T1+ Sequencer Earns CE Mark for EU Access

MGI Tech's T1+ Sequencer Earns CE Mark for EU Access

MGI Tech Achieves CE Mark for DNBSEQ-T1+ Sequencer

MGI Tech Co., Ltd. ("MGI"), known for advancing life sciences, has recently announced its flagship mid-throughput sequencer, the DNBSEQ-T1+ ("T1+"), has successfully received the CE mark. This certification signifies compliance with EU regulations, allowing T1+ to enter European markets for both research and clinical applications.

A Step Forward in Genomic Technologies

Making its initial appearance during the AGBT 2025 event, the T1+ has caught the attention of researchers with its impressive capabilities. This benchtop sequencer is designed for mid-throughput sequencing, delivering a paired-end 150 sequencing workflow that processes results in just 24 hours with Q40 accuracy. This rapid sequencing ability places the T1+ among the fastest options available.

Versatile and Efficient for Labs

The T1+ is characterized by its flexibility, offering three flow cell formats and the capacity to handle two to four addressable lanes within each flow cell. This allows for data output ranging from 25 to 1,200 Gb, enabling researchers to perform independent experiments seamlessly on a single platform, significantly bolstering laboratory efficiency and overall productivity.

Innovative Features Enhance Usability

One of the standout attributes of the T1+ is its integration of advanced auto-DNB making and loading systems, combined with a built-in bioinformatics module. These features simplify the user experience, ensuring a smoother workflow for a diverse range of genomic applications. The straightforward interface enhances the overall user experience, enabling scientists to focus on their research without technological hindrances.

Impact on Genomics and Precision Medicine

Duncan Yu, President of MGI, expressed enthusiasm over the CE marking, affirming that the T1+ meets necessary EU standards. "This certification not only demonstrates our commitment to quality but also empowers researchers and clinicians in Europe to make significant strides in fields like precision medicine and oncology with reliable, efficient, and versatile sequencing technology," Yu noted.

Successful Debut at ESHG Exhibition

The T1+ was showcased at the European market ESHG exhibition, where it garnered significant interest from attendees eager for hands-on experience. The enthusiastic feedback underscores the growing recognition of advanced sequencing technologies and their potential impact on future research methodologies.

About MGI

MGI Tech Co., Ltd. is dedicated to developing vital tools and technologies that steer innovation in life sciences. The company specializes in research and development, manufacturing, and the sales of instruments, reagents, and relevant products in biotechnology and life science. MGI delivers real-time, multi-omics systems and a comprehensive range of digital tools tailored for precision medicine, agriculture, healthcare, and other sectors.

Since its inception in 2016, MGI has established itself as a prominent player in the life sciences arena, serving clients across the globe while setting up research, manufacturing, and training facilities. The company is one of the few capable of independently developing and mass-producing clinical-grade gene sequencers across a wide variety of throughput capacities, from gigabits to terabits. MGI's commitment to innovation and sustainability positions it well to shape the future landscape of life sciences.

Frequently Asked Questions

What is the significance of the CE mark for the T1+ sequencer?

The CE mark indicates compliance with European safety and efficacy standards, allowing the T1+ sequencer to be utilized in research and clinical applications in the EU.

How does the T1+ compare to other sequencers?

The T1+ stands out due to its rapid sequencing time, accuracy, and flexible flow cell options, offering significant advantages in mid-throughput sequencing.

What applications are supported by the T1+ sequencer?

The T1+ is suitable for various genomic applications, enhancing research in fields such as precision medicine, cancer genomics, and agricultural biotechnology.

How has MGI Tech positioned itself in the life sciences sector?

MGI Tech focuses on innovation and quality, establishing itself as a leader in life science tools and technologies, catering to global markets with advanced solutions.

What future developments can be expected from MGI Tech?

MGI is committed to ongoing advancements in sequencing technology, aiming to expand its offerings and impact across research and clinical landscapes worldwide.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Greenberg Traurig Cheers Clients' 69th GRAMMY® Nods

Updated Category News Views 87

A Momentous Occasion for Greenberg Traurig's Entertainment Clients Oh, the glamour and glitz of the music world! There's nothing quite like the GRAMMY® Awards to stir up a blend of excitement, ego, and anxiety in the industry. This time around, the lawyers over at Greenberg Traurig are beaming with pride as their clients scoop up nominations for the 69th Annual GRAMMY®...

Continue Reading
DHL Leverages Robust Growth in Resilient Supply Chains

Updated Category News Views 158

Supply Chain Resilience: A Strategic Game Changer Market volatility's got its teeth in the game, and everyone in logistics knows it. DHL Supply Chain isn't just sitting back; they're riding the wave of change, snagging a 12% revenue bump in 2026. It's not your typical headline growth, either. More like the kind of growth that gets logistics gurus eyeing those contract...

Continue Reading
Alley Cat Allies Pushes for Humane Cat Conservation Bill

Updated Category News Views 70

Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...

Continue Reading
NCPDP Elevates J.W. Hill to President & COO Role

Updated Category News Views 46

Plotting the Course for NCPDP's Future Today's shakeup at the NCPDP has got the sector's ears perked. For those who don't speak in acronym soup all day—NCPDP stands for National Council for Prescription Drug Programs. They're the brains behind many crucial healthcare standards, improving information flow around meds, supplies, and services. Now, they're taking bold...

Continue Reading
Fluence Energy Faces Heat: Class Action Lawsuit Unfolds

Updated Category News Views 73

Fluence Energy's Difficult Waters Investors in Fluence Energy (NASDAQ: FLNC) are having a moment of reckoning, no doubt. November 2nd saw a nearly 9% drop in FLNC stock, further fueled by the sudden departures of the CEO and CFO just days earlier. This marks a bitter chapter for Fluence as its stock continues to bleed, leaving many wondering what seismic shifts are yet to...

Continue Reading
Go NYC's Perks: Making Commutes Rewarding in NYC

Updated Category News Views 104

Go NYC's Perks: Turning Commutes into Gains I’ve seen a lot of schemes aimed at getting folks to change their travel habits, but this one from Go NYC caught my attention. These guys are trying to squeeze some extra value out of the daily grind for anyone hoofing it across the Big Apple. A new rewards program named Perks kicks off, offering all kinds of discounts and...

Continue Reading
Teamsters Ratify Contract, Averting Waste Strike

Updated Category News Views 103

Big Win for Teamsters Local 350 You ever seen a strike averted by sheer willpower and unity? That’s what's happened here with the workers at South San Francisco Scavenger Company. These folks—drivers, mechanics, sorters, and utility workers—all banded together under the Teamsters Local 350 and showed management what's what by securing a contract they deserve. We're...

Continue Reading
Older Adults Embrace Cosmetic Dentistry for Confidence

Updated Category News Views 173

Why the Shift to Cosmetic Dentistry Later in Life? Aging doesn't just wrinkle your skin; it affects your smile too. Dr. Joseph T. Sumrall and Dr. Gran Sumrall, the dental gurus of Warner Robins, Georgia, are laying out why more adults are jumping on the cosmetic dentistry bandwagon as they age. Spoiler: It ain't about getting a movie-star grin but something much deeper....

Continue Reading
Lear Gears Up for Goldman Sachs Event Spotlight

Updated Category News Views 102

Lear Prepares for the Big Stage in London Autumn leaves and industry insights are falling in full swing as Lear Corporation gets its ducks in a row for the upcoming Goldman Sachs 18th Annual Industrials & Autos Week. Kicking off on December 3, 2026, this gathering in London isn't just another checkbox on their corporate calendar—it's a prime moment in the spotlight....

Continue Reading
Lululemon Faces Class Action: Navigating Investor Impact

Updated Category News Views 65

Lululemon's Legal Storm: Understanding the Background If you thought the yoga gear game was all about stretch and flexibility, Lululemon Athletica, Inc (NASDAQ: LULU) just yanked us back to reality. The company finds itself in a legal tangle with its shareholders following a dismal performance report and a subsequent lawsuit. This situation has unfolded like a second-rate...

Continue Reading

Top 5 Most Recently Viewed Articles

Alvotech's Proposed Biosimilar AVT06 Gains EMA Recommendation

Updated Category News Views 266

Positive News from the European Medicines Agency Alvotech (NASDAQ: ALVO), a pioneering biotech firm dedicated to manufacturing biosimilar medications, alongside Advanz Pharma, has recently received encouraging news from the European Medicines Agency (EMA). The Committee for Medicinal Products for Human Use (CHMP) has adopted a favorable opinion recommending the approval...

Continue Reading
Legal Action Alert: Zeta Global Holdings Corp. Investor Rights

Updated Category News Views 152

Legal Action Alert for Zeta Global Holdings Corp. Investors Rosen Law Firm, an established advocate for investor rights, is calling on shareholders of Zeta Global Holdings Corp. (NYSE: ZETA) who have experienced significant losses to get in touch with them. This notice comes in light of a newly filed class-action lawsuit that represents those who purchased Zeta securities...

Continue Reading
Stagwell Inc. Reports Impressive Financial Growth Results

Updated Category News Views 207

Stagwell Inc. Reports Impressive Financial Growth Results Stagwell Inc. (NASDAQ: STGW) has released its financial results for the recent quarter and the full year, showcasing an impressive performance. The report reveals not only year-on-year growth in revenue but also advances in digital transformation, highlighting the company’s robust market position. Fourth Quarter...

Continue Reading
BlocScale Launchpad Advances Tokenization on XRP Ledger

Updated Category News Views 259

Revolutionizing Tokenization with BlocScale Launchpad LIJA, Malta — The BlocScale Launchpad is making headlines by introducing a transformative approach to real-world asset (RWA) tokenization on the XRP Ledger. As a pioneering launchpad for Web3 projects and businesses emerging from various markets, it is gaining traction and establishing itself as a vital platform for...

Continue Reading
Analyzing Vale SA's Current Market Trajectory and Sentiment

Updated Category News Views 93

Exploring Vale SA's Trading Dynamics Vale SA's (NYSE: VALE) recent short interest report reveals a decrease of 6.55% in the short interest as a percentage of float. Currently, there are approximately 66.85 million shares sold short, which constitutes about 1.57% of the shares available for trading. This implies that, on average, it would take around 2.4 days for traders...

Continue Reading